동향
동향 내용
A Guide for the Preparation of Applications for Authorization of Positron=emitting Radiopharmaceuticlas for Use in Basic Clinical Research Studies
분류 Radiopharmaceuticals, Clinical researh, Guidance 조회 2377
발행년도 2014 등록일 2015-10-02
출처 Health Canada (바로가기)
This Guidance document provides information on the interpretation and application of sections C.03.301 to C.03.320 of the Food and Drug Regulations (the Regulations) applicable to positron-emitting radiopharmaceuticals (PERs) used in basic clinical research studies.
 
(후략)

목록



[추천 메일 발송]
추천 메일 발송
받는 분 이메일 @
추천인
리스트 이전글과 다음글
이전글이전글 Safety in Magnetic Resonance Imaging
다음글다음글 Cyclotron Produced Radionuclides: Guidance on Facility Design and Production of [F-18]Fluorodeoxyglucose(FDG)